Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Applied Optics
|
October 25, 2002
Multiple-scattering lidar retrieval method: tests on Monte Carlo simulations and comparisons with in situ measurements
Luc R Bissonnette, Gilles Roy, Laurent Poutier, et al.
Clinical and Experimental Dermatology
|
November 13, 2010
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids
T Dirschka, K Reich, R Bissonnette, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1991
A T helper cell hybridoma produces an antigen-specific regulatory activity. Relationship to the T cell receptor by serology and antigenic fine specificity
R Bissonnette, H G Zheng, R T Kubo, et al.
Journal of Cosmetic Dermatology
|
March 3, 2009
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris
R Bissonnette, C Bolduc, S Seité, et al.
Journal of the American Society for Mass Spectrometry
|
June 1, 2023
First-Principles Modeling of Preferential Solvation in Mixed-Modifier Differential Mobility Spectrometry
Justine R Bissonnette, Christopher R M Ryan, Christian Ieritano, et al.
Applied Optics
|
June 10, 2010
Transmitted beam profiles, integrated backscatter, and rangeresolved backscatter in inhomogeneous laboratory water droplet clouds
L R Bissonnette, R B Smith, A Ulitsky, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 15, 2011
Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial
R Bissonnette, C Bolduc, C Maari, et al.
The British Journal of Dermatology
|
February 8, 2013
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
W C Ports, S Khan, S Lan, et al.
The Journal of Investigative Dermatology
|
October 9, 1998
Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX
R Bissonnette, H Zeng, D I McLean, et al.
Blood
|
March 1, 1994
BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death
A McGahon, R Bissonnette, M Schmitt, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Applied Optics
|
October 25, 2002
Multiple-scattering lidar retrieval method: tests on Monte Carlo simulations and comparisons with in situ measurements
Luc R Bissonnette, Gilles Roy, Laurent Poutier, et al.
Clinical and Experimental Dermatology
|
November 13, 2010
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids
T Dirschka, K Reich, R Bissonnette, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1991
A T helper cell hybridoma produces an antigen-specific regulatory activity. Relationship to the T cell receptor by serology and antigenic fine specificity
R Bissonnette, H G Zheng, R T Kubo, et al.
Journal of Cosmetic Dermatology
|
March 3, 2009
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris
R Bissonnette, C Bolduc, S Seité, et al.
Journal of the American Society for Mass Spectrometry
|
June 1, 2023
First-Principles Modeling of Preferential Solvation in Mixed-Modifier Differential Mobility Spectrometry
Justine R Bissonnette, Christopher R M Ryan, Christian Ieritano, et al.
Applied Optics
|
June 10, 2010
Transmitted beam profiles, integrated backscatter, and rangeresolved backscatter in inhomogeneous laboratory water droplet clouds
L R Bissonnette, R B Smith, A Ulitsky, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 15, 2011
Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial
R Bissonnette, C Bolduc, C Maari, et al.
The British Journal of Dermatology
|
February 8, 2013
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
W C Ports, S Khan, S Lan, et al.
The Journal of Investigative Dermatology
|
October 9, 1998
Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX
R Bissonnette, H Zeng, D I McLean, et al.
Blood
|
March 1, 1994
BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death
A McGahon, R Bissonnette, M Schmitt, et al.
Page
of 11